Vicki Plaks
Senior Director, Scientific Head of Cell Therapy Oncology, Translational Research Johnson & Johnson
Seminars
Wednesday 16th September 2026
Industry Leader’s Fireside Chat: Evaluating the CAR & TCR Therapeutic & Commercial Landscape to Propel Advanced Cell Therapy Innovation, Expand Treatment Options & Ensure Positive Commercial Outcomes
8:20 am
- Highlighting evolving modality innovations and industry shifts to demonstrate how rapid scientific and technological progress is enhancing treatment accessibility and reshaping the cell therapy landscape
- Aligning clinical development, scalability and patient access strategies to accelerate commercialization pathways across advanced cell therapy modalities
- Discussing post-approval reimbursement policies and strategies to ensure long-term commercial success
- Predicting cell therapy evolution through 2026 and beyond to provide strategic and commercial foresight
Wednesday 16th September 2026
Chair’s Opening Remarks
8:15 am
Thursday 17th September 2026
Biomarkers Associated with Safety & Efficacy of Dual Targeting CAR-T Therapies to Treat Lymphoma
11:50 am
- Highlighting biomarker data associated with clinical safety, efficacy from Prizlo-cel anti-CD19/CD20 CAR-T therapy
- Showcasing early efficacy results to illustrate how dual targeting improves clinical response
- Utilizing early success to inform next steps towards expanded clinical use
